FindTrial
Sign In

A medical records based study for Di'ao Xinxuekang Capsules in the treatment of angina pectoris of coronary heart disease

Di'ao Xinxuekang Capsules for angina pectoris of coronary heart disease

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ITMCTR
Registry ID
ITMCTR2200005554
Enrollment
Unknown
Registered
2022-01-23
Start date
2022-01-12
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

angina pectoris of coronary heart disease

Interventions

case series:None

Sponsors

Guangzhou Panyu Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) From January 1, 2011 to December 31, 2021, patients with coronary heart disease who were prescribed Di'ao Xinxuekang Capsules for the first time, or were prescribed Di'ao Xinxuekang Capsules again after at least 30 days of drug withdrawal; 2) Followed the doctor's orders to take medicine, had at least one hospital visit record during taking Di'ao Xinxuekang Capsules, and the interval between the return visit and the initial visit was at least 1 year; 3) Gender and age were not limited.

Exclusion criteria

Exclusion criteria: 1) Cases are considered to affect the evaluation of Di'ao Xinxuekang Capsules and are not suitable for collection.

Design outcomes

Primary

MeasureTime frame
Incidence of major adverse cardiovascular events;Laboratory metrics;Interval between readmissions for coronary heart disease;Seattle angina questionnaire;Indicators of echocardiography;Indicators of twelve-lead ECG;—

Countries

China

Contacts

Public ContactYang Hui
yanghui1234359@sina.com18922238175

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026